Cargando…

Dapagliflozin effect on endothelial dysfunction in diabetic patients with atherosclerotic disease: a randomized active-controlled trial

BACKGROUND: The glucose-lowering independent effect of sodium glucose cotransporter-2 inhibitors (SGLT2i) on arterial wall function has not yet been clarified. This study aims to assess whether SGLT2i treatment can attenuate endothelial dysfunction related to type 2 diabetes mellitus (T2D) compared...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sposito, Andrei C., Breder, Ikaro, Soares, Alexandre A. S., Kimura-Medorima, Sheila T., Munhoz, Daniel B., Cintra, Riobaldo M. R., Bonilha, Isabella, Oliveira, Daniela C., Breder, Jessica Cunha, Cavalcante, Pamela, Moreira, Camila, Moura, Filipe A., de Lima-Junior, Jose Carlos, do Carmo, Helison R. P., Barreto, Joaquim, Nadruz, Wilson, Carvalho, Luiz Sergio F., Quinaglia, Thiago
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004411/ https://www.ncbi.nlm.nih.gov/pubmed/33771149 http://dx.doi.org/10.1186/s12933-021-01264-z

Ejemplares similares

Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus
por: Wolf, Vaneza Lira W., et al.
Publicado: (2021)

Rationale and design of the expanded combination of evolocumab plus empagliflozin in diabetes: EXCEED-BHS3 trial
por: Breder, Ikaro, et al.
Publicado: (2020)

Assessment of dapagliflozin effect on diabetic endothelial dysfunction of brachial artery (ADDENDA-BHS2 trial): rationale, design, and baseline characteristics of a randomized controlled trial
por: Cintra, Riobaldo M. R., et al.
Publicado: (2019)

Evolocumab on top of empagliflozin improves endothelial function of individuals with diabetes: randomized active-controlled trial
por: Sposito, Andrei C., et al.
Publicado: (2022)

Compliance with Cardiovascular Prevention Guidelines in Type 2 Diabetes Individuals in a Middle-Income Region: A Cross-Sectional Analysis
por: Barreto, Joaquim, et al.
Publicado: (2022)

Coronavirus disease-19: The multi-level, multi-faceted vasculopathy
por: Quinaglia, Thiago, et al.
Publicado: (2021)

Dapagliflozin cardiovascular effects on end-stage kidney disease (DARE-ESKD-2) trial: rationale and design
por: Barreto, Joaquim, et al.
Publicado: (2023)

The role of SGLT2i in attenuating residual cardiovascular risk through blood pressure-lowering: mechanistic insights and perspectives
por: Barreto, Joaquim, et al.
Publicado: (2023)

Statin Short-term Inhibition of Insulin Sensitivity and Secretion During Acute Phase of ST-Elevation Myocardial Infarction
por: Sposito, Andrei C., et al.
Publicado: (2019)

Comparative effectiveness and cost-effectiveness of cardioprotective glucose-lowering therapies for type 2 diabetes in Brazil: a Bayesian network model
por: Nogueira, Ana Claudia Cavalcante, et al.
Publicado: (2023)

Very low HDL levels: clinical assessment and management
por: Bonilha, Isabella, et al.
Publicado: (2023)

Diabetic and non-diabetic patients in the intensive care unit: morbidity and mortality
por: Barros, Antonio Carlos, et al.
Publicado: (2015)

TCF7L2 polymorphism is associated with low nitric oxide release, endothelial dysfunction and enhanced inflammatory response after myocardial infarction()
por: Cintra, Riobaldo, et al.
Publicado: (2016)

Informative graphing of continuous safety variables relative to normal reference limits
por: Breder, Christopher D.
Publicado: (2018)

The Reciprocal Relationship between LDL Metabolism and Type 2 Diabetes Mellitus
por: Bonilha, Isabella, et al.
Publicado: (2021)

CSII treatment as an option in high-risk pregnant patients with type 1 diabetes
por: Breder, Íkaro Soares Santos, et al.
Publicado: (2015)

O Impacto da Educação na Mortalidade por Todas as Causas após Infarto do Miocárdio com Supradesnivelamento do Segmento ST (IAMCSST): Resultados do Brasília Heart Study
por: Barreto, Joaquim, et al.
Publicado: (2021)

Synthesis of 1,3‐Dioxan‐2‐ones by Photo‐Aerobic Selenium‐π‐Acid Multicatalysis
por: Müller, Kilian A., et al.
Publicado: (2022)

Glucose-Lowering and the Risk of Cardiovascular Events With Antidiabetic Therapies: A Systematic Review and Additive-Effects Network Meta-Analysis
por: de Carvalho, Luiz Sergio Fernandes, et al.
Publicado: (2022)

Omega-3 intake is associated with attenuated inflammatory response and cardiac remodeling after myocardial infarction
por: Campos-Staffico, Alessandra M., et al.
Publicado: (2019)

Reference intervals for serum immunoglobulin A levels in Brazilian children aged 1 to 10 years: a population-based study
por: Assis, Sandra Breder, et al.
Publicado: (2023)

Aspirin in primary prevention and the risk of heart failure: a systematic review and meta‐analysis of controlled trials
por: de Oliveira, Ana Beatrice Magalhães, et al.
Publicado: (2022)

Patterns of use and impact of standardised MedDRA query analyses on the safety evaluation and review of new drug and biologics license applications
por: Chang, Lin-Chau, et al.
Publicado: (2017)

ST-elevation myocardial infarction risk in the very elderly
por: Campos, Alessandra M., et al.
Publicado: (2016)

Not so critical appraisal of dapagliflozin
por: Doggrell, Sheila A
Publicado: (2014)

Synthesis of Aminoallenes via Selenium‐π‐Acid‐Catalyzed Cross‐Coupling of N‐Fluorinated Sulfonimides with Simple Alkynes
por: Rode, Katharina, et al.
Publicado: (2021)

Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19
por: Carmo, Helison Rafael P., et al.
Publicado: (2023)

SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes
por: Hodrea, Judit, et al.
Publicado: (2022)

Response by Authors to the Letter Regarding Article "Lidocaine and Pinacidil Added to Blood Versus Crystalloid Cardioplegic Solutions: Study in Isolated Hearts"
por: do Carmo, Helison Pereira
Publicado: (2019)

Dysfunctional High-Density Lipoproteins in Type 2 Diabetes Mellitus: Molecular Mechanisms and Therapeutic Implications
por: Bonilha, Isabella, et al.
Publicado: (2021)

Dapagliflozin in patients with COVID-19: mind the kidneys
por: Reis, Thiago, et al.
Publicado: (2022)

P-wave duration is a predictor for long-term mortality in post-CABG patients
por: Kimura-Medorima, Sheila Tatsumi, et al.
Publicado: (2018)

Utility of cfDNA Fragmentation Patterns in Designing the Liquid Biopsy Profiling Panels to Improve Their Sensitivity
por: Ivanov, Maxim, et al.
Publicado: (2019)

Sodium‐Glucose Co‐Transporter 2 (SGLT2) Inhibitor Dapagliflozin Stabilizes Diabetes‐Induced Atherosclerotic Plaque Instability
por: Chen, Yung‐Chih, et al.
Publicado: (2021)

A Comparison of the Pharmacokinetics and Safety of Dapagliflozin Formate, an Ester Prodrug of Dapagliflozin, to Dapagliflozin Propanediol Monohydrate in Healthy Subjects
por: Kim, Hyun Chul, et al.
Publicado: (2023)

The Apoptosis Inhibitor Protein Survivin Is a Critical Cytoprotective Resistor against Silica-Based Nanotoxicity
por: Breder-Bonk, Christina, et al.
Publicado: (2023)

Association of Circulating miR-145-5p and miR-let7c and Atherosclerotic Plaques in Hypertensive Patients
por: Minin, Eduarda O. Z., et al.
Publicado: (2021)

Associação Positiva entre Autoanticorpos contra LDL Oxidada e HDL-C: Um Novo Mecanismo para Cardioproteção de HDL?
por: Nunez, Carla Evelyn Coimbra, et al.
Publicado: (2022)

Diseases Neglected by the Media in Espírito Santo, Brazil in 2011–2012
por: Cavaca, Aline Guio, et al.
Publicado: (2016)

Towards standardization of next-generation sequencing of FFPE samples for clinical oncology: intrinsic obstacles and possible solutions
por: Ivanov, Maxim, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vn09avlpf79uan6aecm8cgg46d